Arcview Collective Fund

Arcview Collective Fund

The Arcview Collective Fund emerged from the Arcview Group, the investor network co-founded by Dayton and DeAngelo that became the central matchmaking platform for accredited investors seeking cannabis exposure. Since its launch, Arcview's summits and pitch forums have facilitated connections between early-stage cannabis founders and a diverse membership base spanning Silicon Valley venture capitalists, Canadian family offices, and high-net-worth individuals from sectors as varied as packaged goods and commercial real estate. The Collective Fund was structured to let members participate in a curated portfolio of Arcview-vetted companies rather than sourcing and underwriting individual deals alone. The fund targets early-stage and growth-stage cannabis companies across the supply chain, from cultivation technology to branded consumer products and ancillary services. Its portfolio has historically included companies touching plant-touching operations in states with mature regulatory frameworks as well as technology platforms serving the broader industry. The investment committee draws on Arcview's proprietary deal-screening process, which reviews hundreds of companies each year through a combination of member voting, expert panels, and structured due-diligence days at quarterly summits. Deals are typically structured as equity rounds with co-investment alongside Arcview's network and select institutional partners. Arcview operates out of New York with additional presences in Darien and Boulder, reflecting the cannabis industry's bicoastal and heartland regulatory patchwork. While the precise AUM and total deployment of the Collective Fund are not publicly disclosed, the Arcview ecosystem by late 2023 had reported facilitating over $400 million in aggregate capital deployment across its network since inception. In November 2023, the group held its final in-person investor summit in Las Vegas, signaling a strategic shift in how it convenes its membership amid a maturing — and increasingly competitive — cannabis capital landscape. What distinguishes Arcview structurally is its origins as a member-owned cooperative model — the fund as deployment arm of a community that itself governs deal access and screening norms. Unlike a traditional venture firm with a closed partnership, the Collective Fund's investment pipeline was always tied to a live network whose members paid to participate in evaluation, making it one of the few earnest experiments in democratized, sector-specific venture capital for an industry that federal prohibition kept off-limits to most institutional allocators.